Products like superabsorbent particles that make one feel full and drugs that target fat-production are part of a new arsenal. There is huge demand because two-thirds of the U.S. population is
overweight. Because federal regulators have rejected drugs recently because of safety concerns, companies are trying different approaches such as physical devices and drugs that target different
metabolic processes.
Read the whole story at The Boston Globe »
